uterine cancer
JP Morgan Healthcare Day 3: Natera, Exact Sciences, Accelerate Dx, GenMark, OraSure, Quidel, Invitae, Opko
Natera discussed its cancer and transplant rejection testing businesses, while Exact Sciences explained how it will benefit from its Genomic Health acquisition.
The team analyzed multigene panel test data from Ambry Genetics for 165,000 individuals, focusing on hereditary cancer risk related to 32 genes in six cancer types.